HEADER HYDROLASE/HYDROLASE INHIBITOR 05-AUG-14 4U8W TITLE HIV-1 WILD TYPE PROTEASE WITH GRL-050-10A (A GEM-DIFLUORO-BIS- TITLE 2 TETRAHYDROFURAN AS P2-LIGAND) COMPND MOL_ID: 1; COMPND 2 MOLECULE: HIV-1 PROTEASE; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 501-599; COMPND 5 EC: 3.4.23.16; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 BH10; SOURCE 3 ORGANISM_COMMON: HIV-1; SOURCE 4 ORGANISM_TAXID: 11678; SOURCE 5 GENE: GAG-POL; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET11A KEYWDS HIV-1 PROTEASE INHIBITOR, MULTIDRUG-RESISTANT HIV-1 STRAINS, BLOOD- KEYWDS 2 BRAIN-BARRIER, FLUORO-BIS-THF, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR Y.-F.WANG,J.AGNISWAMY,I.T.WEBER REVDAT 5 27-SEP-23 4U8W 1 REMARK LINK REVDAT 4 25-DEC-19 4U8W 1 REMARK REVDAT 3 27-SEP-17 4U8W 1 SOURCE REMARK REVDAT 2 31-DEC-14 4U8W 1 JRNL REVDAT 1 05-NOV-14 4U8W 0 JRNL AUTH A.K.GHOSH,S.YASHCHUK,A.MIZUNO,N.CHAKRABORTY,J.AGNISWAMY, JRNL AUTH 2 Y.F.WANG,M.AOKI,P.M.GOMEZ,M.AMANO,I.T.WEBER,H.MITSUYA JRNL TITL DESIGN OF GEM-DIFLUORO-BIS-TETRAHYDROFURAN AS P2 LIGAND FOR JRNL TITL 2 HIV-1 PROTEASE INHIBITORS TO IMPROVE BRAIN PENETRATION: JRNL TITL 3 SYNTHESIS, X-RAY STUDIES, AND BIOLOGICAL EVALUATION. JRNL REF CHEMMEDCHEM V. 10 107 2015 JRNL REFN ESSN 1860-7187 JRNL PMID 25336073 JRNL DOI 10.1002/CMDC.201402358 REMARK 2 REMARK 2 RESOLUTION. 1.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.2 REMARK 3 CROSS-VALIDATION METHOD : FREE R REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.156 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.154 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.188 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 2797 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 55919 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.143 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.141 REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.175 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 2348 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 46749 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1512 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 52 REMARK 3 SOLVENT ATOMS : 141 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 1681.4 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 1635.9 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 40 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 17764 REMARK 3 NUMBER OF RESTRAINTS : 25581 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.012 REMARK 3 ANGLE DISTANCES (A) : 0.032 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.041 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.068 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.066 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.029 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.004 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.037 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.077 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH AND HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: ANISOTROPIC REFINEMENT REDUCED FREE R REMARK 3 (NO CUTOFF) BY ? REMARK 4 REMARK 4 4U8W COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-AUG-14. REMARK 100 THE DEPOSITION ID IS D_1000203008. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-DEC-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-BM REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 56059 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.300 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.4 REMARK 200 DATA REDUNDANCY : 5.400 REMARK 200 R MERGE (I) : 0.06200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 19.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.35 REMARK 200 COMPLETENESS FOR SHELL (%) : 75.9 REMARK 200 DATA REDUNDANCY IN SHELL : 2.20 REMARK 200 R MERGE FOR SHELL (I) : 0.40500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3NU3 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.61 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.71 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1M NACL, 0.1 M NA ACETATE, PH 4.8, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 29.26950 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 42.99450 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 29.26950 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 42.99450 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4780 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9380 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -57.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 8 NE - CZ - NH1 ANGL. DEV. = -4.3 DEGREES REMARK 500 ASP A 30 CB - CG - OD2 ANGL. DEV. = 5.8 DEGREES REMARK 500 ARG A 41 CD - NE - CZ ANGL. DEV. = 13.5 DEGREES REMARK 500 ARG A 41 NE - CZ - NH1 ANGL. DEV. = 5.0 DEGREES REMARK 500 ILE A 47 CA - C - N ANGL. DEV. = 14.4 DEGREES REMARK 500 ILE A 47 O - C - N ANGL. DEV. = 10.7 DEGREES REMARK 500 ILE A 47 O - C - N ANGL. DEV. = -11.9 DEGREES REMARK 500 ARG A 57 CD - NE - CZ ANGL. DEV. = 10.9 DEGREES REMARK 500 ARG A 57 NE - CZ - NH2 ANGL. DEV. = -3.4 DEGREES REMARK 500 ARG A 87 NE - CZ - NH1 ANGL. DEV. = 3.2 DEGREES REMARK 500 ARG B 8 CD - NE - CZ ANGL. DEV. = 8.8 DEGREES REMARK 500 ARG B 8 NE - CZ - NH1 ANGL. DEV. = 4.2 DEGREES REMARK 500 ASP B 30 CB - CG - OD2 ANGL. DEV. = 5.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 350 DISTANCE = 6.31 ANGSTROMS REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA A 202 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 60 O REMARK 620 2 HOH A 321 O 93.8 REMARK 620 3 HOH A 322 O 103.9 75.8 REMARK 620 4 HOH A 323 O 80.0 172.9 102.1 REMARK 620 5 HOH A 355 O 169.0 89.6 87.2 97.1 REMARK 620 6 HOH A 368 O 97.0 91.4 156.0 92.8 72.4 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue G10 A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NA A 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 203 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL B 101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL B 102 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT B 103 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT B 104 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2IEN RELATED DB: PDB REMARK 900 HIV-1 WILD TYPE PROTEASE WITH DAURNAVIR (BIS-TETRAHYDROFURAN P2- REMARK 900 LIGAND) REMARK 900 RELATED ID: 3QAA RELATED DB: PDB REMARK 900 HIV-1 WILD TYPE PROTEASE WITH GRL-044-10A (A SUBSTITUTED BIS- REMARK 900 TETRAHYDROFURAN P2-LIGAND) REMARK 900 RELATED ID: 3OK9 RELATED DB: PDB REMARK 900 HIV-1 WILD TYPE PROTEASE WITH GRL-0519A (TRIS-TETRAHYDROFURAN P2- REMARK 900 LIGAND) DBREF 4U8W A 1 99 UNP P03366 POL_HV1B1 501 599 DBREF 4U8W B 1 99 UNP P03366 POL_HV1B1 501 599 SEQADV 4U8W LYS A 7 UNP P03366 GLN 507 ENGINEERED MUTATION SEQADV 4U8W ILE A 33 UNP P03366 LEU 533 ENGINEERED MUTATION SEQADV 4U8W ILE A 63 UNP P03366 LEU 563 ENGINEERED MUTATION SEQADV 4U8W ALA A 67 UNP P03366 CYS 567 ENGINEERED MUTATION SEQADV 4U8W ALA A 95 UNP P03366 CYS 595 ENGINEERED MUTATION SEQADV 4U8W LYS B 7 UNP P03366 GLN 507 ENGINEERED MUTATION SEQADV 4U8W ILE B 33 UNP P03366 LEU 533 ENGINEERED MUTATION SEQADV 4U8W ILE B 63 UNP P03366 LEU 563 ENGINEERED MUTATION SEQADV 4U8W ALA B 67 UNP P03366 CYS 567 ENGINEERED MUTATION SEQADV 4U8W ALA B 95 UNP P03366 CYS 595 ENGINEERED MUTATION SEQRES 1 A 99 PRO GLN ILE THR LEU TRP LYS ARG PRO LEU VAL THR ILE SEQRES 2 A 99 LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR SEQRES 3 A 99 GLY ALA ASP ASP THR VAL ILE GLU GLU MET SER LEU PRO SEQRES 4 A 99 GLY ARG TRP LYS PRO LYS MET ILE GLY GLY ILE GLY GLY SEQRES 5 A 99 PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE ILE ILE GLU SEQRES 6 A 99 ILE ALA GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY SEQRES 7 A 99 PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR SEQRES 8 A 99 GLN ILE GLY ALA THR LEU ASN PHE SEQRES 1 B 99 PRO GLN ILE THR LEU TRP LYS ARG PRO LEU VAL THR ILE SEQRES 2 B 99 LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR SEQRES 3 B 99 GLY ALA ASP ASP THR VAL ILE GLU GLU MET SER LEU PRO SEQRES 4 B 99 GLY ARG TRP LYS PRO LYS MET ILE GLY GLY ILE GLY GLY SEQRES 5 B 99 PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE ILE ILE GLU SEQRES 6 B 99 ILE ALA GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY SEQRES 7 B 99 PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR SEQRES 8 B 99 GLN ILE GLY ALA THR LEU ASN PHE HET G10 A 201 80 HET NA A 202 1 HET CL A 203 1 HET CL B 101 1 HET CL B 102 1 HET ACT B 103 4 HET ACT B 104 4 HETNAM G10 (3R,3AS,6AS)-4,4-DIFLUOROHEXAHYDROFURO[2,3-B]FURAN-3-YL HETNAM 2 G10 [(2S,3R)-4-{[(4-AMINOPHENYL)SULFONYL](2-METHYLPROPYL) HETNAM 3 G10 AMINO}-3-HYDROXY-1-PHENYLBUTAN-2-YL]CARBAMATE HETNAM NA SODIUM ION HETNAM CL CHLORIDE ION HETNAM ACT ACETATE ION FORMUL 3 G10 C27 H35 F2 N3 O7 S FORMUL 4 NA NA 1+ FORMUL 5 CL 3(CL 1-) FORMUL 8 ACT 2(C2 H3 O2 1-) FORMUL 10 HOH *141(H2 O) HELIX 1 AA1 GLY A 86 THR A 91 1 6 HELIX 2 AA2 GLN A 92 GLY A 94 5 3 HELIX 3 AA3 GLY B 86 THR B 91 1 6 SHEET 1 AA1 4 GLN A 2 ILE A 3 0 SHEET 2 AA1 4 THR B 96 ASN B 98 -1 O LEU B 97 N ILE A 3 SHEET 3 AA1 4 THR A 96 ASN A 98 -1 N THR A 96 O ASN B 98 SHEET 4 AA1 4 GLN B 2 ILE B 3 -1 O ILE B 3 N LEU A 97 SHEET 1 AA2 8 TRP A 42 ILE A 47 0 SHEET 2 AA2 8 ILE A 54 ILE A 66 -1 O GLN A 58 N LYS A 43 SHEET 3 AA2 8 HIS A 69 VAL A 77 -1 O HIS A 69 N ILE A 66 SHEET 4 AA2 8 THR A 31 ILE A 33 1 N ILE A 33 O LEU A 76 SHEET 5 AA2 8 ILE A 84 ILE A 85 -1 O ILE A 84 N VAL A 32 SHEET 6 AA2 8 GLN A 18 LEU A 24 1 N LEU A 23 O ILE A 85 SHEET 7 AA2 8 LEU A 10 ILE A 15 -1 N ILE A 13 O LYS A 20 SHEET 8 AA2 8 ILE A 54 ILE A 66 -1 O GLU A 65 N LYS A 14 SHEET 1 AA3 8 LYS B 43 GLY B 49 0 SHEET 2 AA3 8 GLY B 52 ILE B 66 -1 O GLN B 58 N LYS B 43 SHEET 3 AA3 8 HIS B 69 VAL B 77 -1 O HIS B 69 N ILE B 66 SHEET 4 AA3 8 VAL B 32 ILE B 33 1 N ILE B 33 O LEU B 76 SHEET 5 AA3 8 ILE B 84 ILE B 85 -1 O ILE B 84 N VAL B 32 SHEET 6 AA3 8 GLN B 18 LEU B 24 1 N LEU B 23 O ILE B 85 SHEET 7 AA3 8 LEU B 10 ILE B 15 -1 N ILE B 13 O LYS B 20 SHEET 8 AA3 8 GLY B 52 ILE B 66 -1 O GLU B 65 N LYS B 14 LINK O ASP A 60 NA NA A 202 1555 1555 2.36 LINK NA NA A 202 O HOH A 321 1555 1555 2.49 LINK NA NA A 202 O HOH A 322 1555 1555 2.28 LINK NA NA A 202 O HOH A 323 1555 1555 2.28 LINK NA NA A 202 O HOH A 355 1555 1555 2.76 LINK NA NA A 202 O HOH A 368 1555 1555 2.47 SITE 1 AC1 32 ASP A 25 GLY A 27 ALA A 28 ASP A 29 SITE 2 AC1 32 ASP A 30 VAL A 32 GLY A 48 GLY A 49 SITE 3 AC1 32 ILE A 50 PRO A 81 VAL A 82 ILE A 84 SITE 4 AC1 32 HOH A 318 HOH A 319 HOH A 339 ARG B 8 SITE 5 AC1 32 ASP B 25 GLY B 27 ALA B 28 ASP B 29 SITE 6 AC1 32 ASP B 30 VAL B 32 GLY B 48 GLY B 49 SITE 7 AC1 32 ILE B 50 PRO B 81 VAL B 82 ILE B 84 SITE 8 AC1 32 HOH B 224 HOH B 225 HOH B 270 HOH B 271 SITE 1 AC2 6 ASP A 60 HOH A 321 HOH A 322 HOH A 323 SITE 2 AC2 6 HOH A 355 HOH A 368 SITE 1 AC3 3 THR A 74 ASN A 88 ARG B 41 SITE 1 AC4 2 TRP B 6 ACT B 104 SITE 1 AC5 3 THR B 74 ASN B 88 HOH B 234 SITE 1 AC6 6 PRO B 39 ARG B 41 TYR B 59 ASP B 60 SITE 2 AC6 6 HOH B 253 HOH B 254 SITE 1 AC7 4 THR B 4 PRO B 44 LYS B 55 CL B 101 CRYST1 58.539 85.989 46.210 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017083 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011629 0.000000 0.00000 SCALE3 0.000000 0.000000 0.021640 0.00000